2004 Volume 55 Issue 6 Pages 446-453
The medical practice statistical in our department of the laryngeal cancer case was examined. In all, we were able to follow 104 patients for more than five years between 1985 and 1997. Ages ranged from 39 to 82 years old (61.8 average), and the ratio of male to female was 14:1 (97 males, 7 females).
Supraglottic cancer was found in 22.1% (23 patients), glottic cancer in 72.1% (75 patients) and subglottic cancer in 5.8% (6 patients). According to the UICC TNM classification system, 52 patients (50.0%) were in stage I, 27 (26.0%) in stage II, 10 (9.6%) in stage III, and 15 (14.4%) in stage IV.
The five-year survival rate for supraglottic cancer was 60.9%, for glottic cancer 94.7%, for subglottic cancer patients 86.5%, and for all patients 83.3%. The five-year survival rate was 96.2% for stage I, 92.6% for stage II, 100% for stage III, and 33.3% for stage IV.
A poor prognosis for patients in stage I and stage II was given for those with supraglottic cancer, with those of N2 and N3 most prevalent, according to N classification. These findings suggest that chemotherapy should be aggressively carried out for poor-prognosis cases.
